Evidence-based therapies for myocardial infarction

Secular trends and determinants of practice in the community

James M. Perschbacher, Guy S. Reeder, Steven J. Jacobsen, Susan A. Weston, Jill M. Killian, Adriana Slobodova, Veronique Lee Roger

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

OBJECTIVES: To examine secular trends in the use of evidence-based therapies in a geographically defined cohort of patients with myocardial infarction (MI) and to test the hypotheses that baseline use is increasing and that disparities in use are diminishing. PATIENTS AND METHODS: All consecutively hospitalized patients who were dismissed from Olmsted County, Minnesota, hospitals between 1979 and 1998 with a diagnosis of MI were identified using standardized criteria (biomarkers, cardiac pain, and electrocardiography). The entire community medical record, available via the Rochester Epidemiology Project, was reviewed to ascertain baseline characteristics including comorbidity, presence of ST-segment elevation on electrocardiography, and treatment. Logistic regression models were used to examine the association of treatment with age and sex, independent of other baseline characteristics. RESULTS: Between 1979 and 1998, 2317 Incident MIs (patient mean ± SD age, 67±14 years; 43% women; 57% aged ge;65 years) occurred in Olmsted County. The use of all evidence-based therapies increased over time, primarily reflecting the introduction of these medications at the time of index MI. Between 1389 and 1398, age was not independently associated with use of aspirin or ACE Inhibitors. Disparities in use persisted for reperfusion therapy and β-blockers. Reperfushion therapy or revascularization was used less frequently in older persons, particularly in elderly women (P<.001). Use of β-blockers decreased 16% among persons aged 65 years or older, independent of measurable differences in baseline characteristics and MI severity (hazard ratio, 0.84; 95% confidence Interval, 0.74-0.93). CONCLUSIONS: The use of all evidence-based therapies for MI increased markedly over time; however, residual gaps in use were noted. Reperfusion therapy or revascularization is used less frequently in women and elderly persons, and β-blockers are used less frequently in elderly persons. These differences are not explained by measurable differences in baseline characteristics. Women and elderly persons represent an increasing proportion of patients with MIs in the community; therefore, these findings define therapeutic opportunities.

Original languageEnglish (US)
Pages (from-to)983-991
Number of pages9
JournalMayo Clinic Proceedings
Volume79
Issue number8
StatePublished - 2004

Fingerprint

Myocardial Infarction
Therapeutics
Reperfusion
Electrocardiography
Logistic Models
County Hospitals
Angiotensin-Converting Enzyme Inhibitors
Aspirin
Medical Records
Comorbidity
Epidemiology
Biomarkers
Confidence Intervals
Pain

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Perschbacher, J. M., Reeder, G. S., Jacobsen, S. J., Weston, S. A., Killian, J. M., Slobodova, A., & Roger, V. L. (2004). Evidence-based therapies for myocardial infarction: Secular trends and determinants of practice in the community. Mayo Clinic Proceedings, 79(8), 983-991.

Evidence-based therapies for myocardial infarction : Secular trends and determinants of practice in the community. / Perschbacher, James M.; Reeder, Guy S.; Jacobsen, Steven J.; Weston, Susan A.; Killian, Jill M.; Slobodova, Adriana; Roger, Veronique Lee.

In: Mayo Clinic Proceedings, Vol. 79, No. 8, 2004, p. 983-991.

Research output: Contribution to journalArticle

Perschbacher, JM, Reeder, GS, Jacobsen, SJ, Weston, SA, Killian, JM, Slobodova, A & Roger, VL 2004, 'Evidence-based therapies for myocardial infarction: Secular trends and determinants of practice in the community', Mayo Clinic Proceedings, vol. 79, no. 8, pp. 983-991.
Perschbacher JM, Reeder GS, Jacobsen SJ, Weston SA, Killian JM, Slobodova A et al. Evidence-based therapies for myocardial infarction: Secular trends and determinants of practice in the community. Mayo Clinic Proceedings. 2004;79(8):983-991.
Perschbacher, James M. ; Reeder, Guy S. ; Jacobsen, Steven J. ; Weston, Susan A. ; Killian, Jill M. ; Slobodova, Adriana ; Roger, Veronique Lee. / Evidence-based therapies for myocardial infarction : Secular trends and determinants of practice in the community. In: Mayo Clinic Proceedings. 2004 ; Vol. 79, No. 8. pp. 983-991.
@article{81d39a20aeaf44239729a78d6e2ccce9,
title = "Evidence-based therapies for myocardial infarction: Secular trends and determinants of practice in the community",
abstract = "OBJECTIVES: To examine secular trends in the use of evidence-based therapies in a geographically defined cohort of patients with myocardial infarction (MI) and to test the hypotheses that baseline use is increasing and that disparities in use are diminishing. PATIENTS AND METHODS: All consecutively hospitalized patients who were dismissed from Olmsted County, Minnesota, hospitals between 1979 and 1998 with a diagnosis of MI were identified using standardized criteria (biomarkers, cardiac pain, and electrocardiography). The entire community medical record, available via the Rochester Epidemiology Project, was reviewed to ascertain baseline characteristics including comorbidity, presence of ST-segment elevation on electrocardiography, and treatment. Logistic regression models were used to examine the association of treatment with age and sex, independent of other baseline characteristics. RESULTS: Between 1979 and 1998, 2317 Incident MIs (patient mean ± SD age, 67±14 years; 43{\%} women; 57{\%} aged ge;65 years) occurred in Olmsted County. The use of all evidence-based therapies increased over time, primarily reflecting the introduction of these medications at the time of index MI. Between 1389 and 1398, age was not independently associated with use of aspirin or ACE Inhibitors. Disparities in use persisted for reperfusion therapy and β-blockers. Reperfushion therapy or revascularization was used less frequently in older persons, particularly in elderly women (P<.001). Use of β-blockers decreased 16{\%} among persons aged 65 years or older, independent of measurable differences in baseline characteristics and MI severity (hazard ratio, 0.84; 95{\%} confidence Interval, 0.74-0.93). CONCLUSIONS: The use of all evidence-based therapies for MI increased markedly over time; however, residual gaps in use were noted. Reperfusion therapy or revascularization is used less frequently in women and elderly persons, and β-blockers are used less frequently in elderly persons. These differences are not explained by measurable differences in baseline characteristics. Women and elderly persons represent an increasing proportion of patients with MIs in the community; therefore, these findings define therapeutic opportunities.",
author = "Perschbacher, {James M.} and Reeder, {Guy S.} and Jacobsen, {Steven J.} and Weston, {Susan A.} and Killian, {Jill M.} and Adriana Slobodova and Roger, {Veronique Lee}",
year = "2004",
language = "English (US)",
volume = "79",
pages = "983--991",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "8",

}

TY - JOUR

T1 - Evidence-based therapies for myocardial infarction

T2 - Secular trends and determinants of practice in the community

AU - Perschbacher, James M.

AU - Reeder, Guy S.

AU - Jacobsen, Steven J.

AU - Weston, Susan A.

AU - Killian, Jill M.

AU - Slobodova, Adriana

AU - Roger, Veronique Lee

PY - 2004

Y1 - 2004

N2 - OBJECTIVES: To examine secular trends in the use of evidence-based therapies in a geographically defined cohort of patients with myocardial infarction (MI) and to test the hypotheses that baseline use is increasing and that disparities in use are diminishing. PATIENTS AND METHODS: All consecutively hospitalized patients who were dismissed from Olmsted County, Minnesota, hospitals between 1979 and 1998 with a diagnosis of MI were identified using standardized criteria (biomarkers, cardiac pain, and electrocardiography). The entire community medical record, available via the Rochester Epidemiology Project, was reviewed to ascertain baseline characteristics including comorbidity, presence of ST-segment elevation on electrocardiography, and treatment. Logistic regression models were used to examine the association of treatment with age and sex, independent of other baseline characteristics. RESULTS: Between 1979 and 1998, 2317 Incident MIs (patient mean ± SD age, 67±14 years; 43% women; 57% aged ge;65 years) occurred in Olmsted County. The use of all evidence-based therapies increased over time, primarily reflecting the introduction of these medications at the time of index MI. Between 1389 and 1398, age was not independently associated with use of aspirin or ACE Inhibitors. Disparities in use persisted for reperfusion therapy and β-blockers. Reperfushion therapy or revascularization was used less frequently in older persons, particularly in elderly women (P<.001). Use of β-blockers decreased 16% among persons aged 65 years or older, independent of measurable differences in baseline characteristics and MI severity (hazard ratio, 0.84; 95% confidence Interval, 0.74-0.93). CONCLUSIONS: The use of all evidence-based therapies for MI increased markedly over time; however, residual gaps in use were noted. Reperfusion therapy or revascularization is used less frequently in women and elderly persons, and β-blockers are used less frequently in elderly persons. These differences are not explained by measurable differences in baseline characteristics. Women and elderly persons represent an increasing proportion of patients with MIs in the community; therefore, these findings define therapeutic opportunities.

AB - OBJECTIVES: To examine secular trends in the use of evidence-based therapies in a geographically defined cohort of patients with myocardial infarction (MI) and to test the hypotheses that baseline use is increasing and that disparities in use are diminishing. PATIENTS AND METHODS: All consecutively hospitalized patients who were dismissed from Olmsted County, Minnesota, hospitals between 1979 and 1998 with a diagnosis of MI were identified using standardized criteria (biomarkers, cardiac pain, and electrocardiography). The entire community medical record, available via the Rochester Epidemiology Project, was reviewed to ascertain baseline characteristics including comorbidity, presence of ST-segment elevation on electrocardiography, and treatment. Logistic regression models were used to examine the association of treatment with age and sex, independent of other baseline characteristics. RESULTS: Between 1979 and 1998, 2317 Incident MIs (patient mean ± SD age, 67±14 years; 43% women; 57% aged ge;65 years) occurred in Olmsted County. The use of all evidence-based therapies increased over time, primarily reflecting the introduction of these medications at the time of index MI. Between 1389 and 1398, age was not independently associated with use of aspirin or ACE Inhibitors. Disparities in use persisted for reperfusion therapy and β-blockers. Reperfushion therapy or revascularization was used less frequently in older persons, particularly in elderly women (P<.001). Use of β-blockers decreased 16% among persons aged 65 years or older, independent of measurable differences in baseline characteristics and MI severity (hazard ratio, 0.84; 95% confidence Interval, 0.74-0.93). CONCLUSIONS: The use of all evidence-based therapies for MI increased markedly over time; however, residual gaps in use were noted. Reperfusion therapy or revascularization is used less frequently in women and elderly persons, and β-blockers are used less frequently in elderly persons. These differences are not explained by measurable differences in baseline characteristics. Women and elderly persons represent an increasing proportion of patients with MIs in the community; therefore, these findings define therapeutic opportunities.

UR - http://www.scopus.com/inward/record.url?scp=3442893543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3442893543&partnerID=8YFLogxK

M3 - Article

VL - 79

SP - 983

EP - 991

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 8

ER -